NEU 6.22% $14.62 neuren pharmaceuticals limited

Share Price, page-11525

  1. 2,614 Posts.
    lightbulb Created with Sketch. 417
    In my opinion the price has been controlled since our second positive trial results.

    It was recognized that there were few shares on offer for larger players to snap up and gain a reasonable (for them) position, so they (in my opinion) have been doing their thing to increase their holdings - evident by the fact that instos have apparently increased their holdings by 2.5 million as suggested earlier, while the share price has suffered.

    As also suggested, these instos are happy with a reasonable return in a reasonable time period (ie short compared to long termers here) so I hope it all doesn’t end in disappointment for us long termers,

    There’s a view the selling is just rebalancing, and the natural play with sell downs due to poor Daybue results but I do not hold this view. A sell down from instos is not evident if they’ve increased holdings as suggested.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$14.62
Change
-0.970(6.22%)
Mkt cap ! $1.918B
Open High Low Value Volume
$15.38 $15.40 $14.62 $2.951M 197.1K

Buyers (Bids)

No. Vol. Price($)
3 18 $14.61
 

Sellers (Offers)

Price($) Vol. No.
$14.63 419 8
View Market Depth
Last trade - 11.59am 02/09/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.